摘要OBJECTIVE:To evaluate the effect of berberine on morphine analgesia,tolerance,and hyperalgesia.METHODS:Morphine-induced acute tolerance model:mice received intraperitoneal berberine at doses of 2.5,5.0,and 10 mg/kg;30 min later,subcutaneous morphine 10 mg/kg was injected every hour for nine continuous h.Morphine 10 mg/kg alone was administered at 24 and 48 h.Morphine-induced chronic tolerance model:mice received intraperitoneal berberine 2.5,5.0,and 10 mg/kg;30 min later,10 mg/kg morphine was injected subcutaneously for eight consecutive days.On the ninth day,morphine 10 mg/kg was given alone.Morphine-induced established tolerance model:mice were injected subcutaneously with morphine 10 mg/kg once a day for eight consecutive days.Berberine 2.5 mg/kg was administered on day one,four,and seven and morphine 10 mg/kg alone on day nine.The baseline latency(TO)and post-treatment latency(T1)were determined by the hot plate test,and the maximum possible analgesic effect(MPAE)was calculated.Nitric oxide synthase(NOS)activity and nitric oxide(NO)content in the spinal cord were measured by spectrophotometer.Verification of berberine analgesic effect by blocking N-methyl-D-aspartate(NMDA)receptor:HT-22 and HEK-293 cells transfected with NMDA plasmid were randomly divided into five groups:control group,NMDA group,berberine low-dose,medium-dose,and high-dose groups(5,10,20 μmol/L,respectively).Except for the control group,cells were treated with NMDA(HT-22 cells:20 mmol/L;HEK-293 cells:50 μmol/L).After 24 h,cell viability was detected by cell counting kit-8.The molecular mechanism between berberine and the NMDA receptor was studied by molecular docking.RESULTS:Berberine 2.5 and 5.0 mg/kg could prolong the analgesic time of morphine.In acute and chronic morphine tolerance models,berberine could inhibit the decrease of MPAE and baseline latency(P＜0.05).In the established tolerance model,berberine could rapidly reverse the decreased MPAE(P＜0.05).The combination of berberine and morphine on day one could effectively inhibit the morphine-induced increase of NOS activity and NO content in the spinal cord(P＜0.05).Berberine significantly increased the cell viability of NMDA-induced nerve injury in HT-22 and HEK-293 cells(P＜0.05).Molecular docking showed that berberine binds to the receptor pocket of NMDA.CONCLUSIONS:Berberine could effectively enhance and prolong the duration of morphine analgesia and inhibit the development of morphine-induced tolerance and hyperalgesia.Furthermore,berberine has a certain neuroprotective effect,which may be related to the inhibition of NMDA activity.